Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
For sunscreen use: apply liberally 15 minutes before sun exposure reapply at least every 2 hours use water resistant sunscreen if swimming or sweating Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 ...
protect the product in this container from excessive heat and direct sun
Drug Facts
| Active Ingredients | Purpose |
|---|---|
| Octinoxate 5.00% | Sunscreen |
| Zinc Oxide 18.60% | Sunscreen |
For external use only.
Do not use on damaged or broken skin.
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs.
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
For sunscreen use:
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
Butylphenyl Methyl Propional, C12-15 Alkyl Benzoate, Caprylic/Capric Triglyceride, Caprylyl Glycol, Cyclopentasiloxane, Decarboxy Carnosine HCl, Dimethicone, Dimethicone Crosspolymer, Ethylhexylglycerin, Fragrance/Parfum, Glycerin, Helianthus Annuus (Sunflower) Seed Oil, Hexyl Cinnamic Aldehyde, Hexylene Glycol, Hydroxypropylcocoate PEG-8 Dimethicone, Isododecane, Isopentyldiol, Limonene, Linalool, Palmitoyl Tripeptide-37, PEG/PPG-18/18 Dimethicone, Phenoxyethanol, Physalis Angulata Extract, Phytic Acid, Polyhydroxystearic Acid, Propylene Carbonate, Pyrus Malus (Apple) Fruit Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Silica, Sodium Chloride, Sodium Hydroxide, Tin Oxide, Tocopherol, Triethoxycaprylylsilane, Water (Aqua), May Contain (+/-): Mica, Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499) <ILNJ121030>.
janecosmetics.com
Dist. by Jewel of Jane, LLC Glendale, CA
91209 • Biorius Sprl 2 Rue René
Descartes b-7000 Mons, Belgium
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76049-121-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cd21-f424-e053-dadaa90a57ce | jane. ® Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 |
| 76049-122-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cd21-f424-e053-dadaa90a57ce | jane. ® Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 |
| 76049-123-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cd21-f424-e053-dadaa90a57ce | jane. ® Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76049-121-01 | jane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Dark | 30 mL in 1 TUBE | CREAM | 30 | 1 | |
| 76049-122-01 | jane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Medium | 30 mL in 1 TUBE | CREAM | 30 | 1 | |
| 76049-123-01 | jane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Light | 30 mL in 1 TUBE | CREAM | 30 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76049-121 | JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 LIGHT (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 MEDIUM (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 DARK (OCTINOXATE AND ZINC OXIDE) CREAM [STILA STYLES] | 1 | Legacy NDC, 1 package rows | 20140117_37154826-c34a-416d-a9a3-5004156dccd6.zip |
| 76049-122 | JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 LIGHT (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 MEDIUM (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 DARK (OCTINOXATE AND ZINC OXIDE) CREAM [STILA STYLES] | 1 | Legacy NDC, 1 package rows | 20140117_37154826-c34a-416d-a9a3-5004156dccd6.zip |
| 76049-123 | JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 LIGHT (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 MEDIUM (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 DARK (OCTINOXATE AND ZINC OXIDE) CREAM [STILA STYLES] | 1 | Legacy NDC, 1 package rows | 20140117_37154826-c34a-416d-a9a3-5004156dccd6.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .Alpha.-Hexylcinnamaldehyde | INACTIVE INGREDIENT | 7X6O37OK2I | 1 | |
| Alkyl (C12-15) Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| Apple | INACTIVE INGREDIENT | B423VGH5S9 | 1 | |
| Butylphenyl Methylpropional | INACTIVE INGREDIENT | T7540GJV69 | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| Decarboxy Carnosine Hydrochloride | INACTIVE INGREDIENT | 6X7K9I5QR7 | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| Ferrosoferric Oxide | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| Fytic Acid | INACTIVE INGREDIENT | 7IGF0S7R8I | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Hexylene Glycol | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| Hydroxypropylcocoate Peg-8 Dimethicone | INACTIVE INGREDIENT | 8TE0BZU36S | 1 | |
| Isododecane | INACTIVE INGREDIENT | A8289P68Y2 | 1 | |
| Isopentyldiol | INACTIVE INGREDIENT | 19NOL5474Q | 1 | |
| Linalool, (+/-)- | INACTIVE INGREDIENT | D81QY6I88E | 1 | |
| Medium-Chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| PEG/PPG-18/18 Dimethicone | INACTIVE INGREDIENT | 9H0AO7T794 | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Physalis Angulata | INACTIVE INGREDIENT | W4TKW9D5GG | 1 | |
| Propylene Carbonate | INACTIVE INGREDIENT | 8D08K3S51E | 1 | |
| Rosemary | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| Stannic Oxide | INACTIVE INGREDIENT | KM7N50LOS6 | 1 | |
| Sunflower Oil | INACTIVE INGREDIENT | 3W1JG795YI | 1 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76049-123 | 76049-123-01 |
| 76049-122 | 76049-122-01 |
| 76049-121 | 76049-121-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBMUCOSAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT, AUGMENTED / TOPICAL | 0.11 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACARDIAC | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVESICAL | 351 mg | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | POWDER, FOR SUSPENSION / ORAL | NA | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | PASTE / DENTAL | 0.6 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / ORAL | 24 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED / ORAL | 0.08 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | 36 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRADERMAL | 7 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAOCULAR | 320 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, EXTENDED RELEASE / ORAL | 7 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTERIAL | 176 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY / TOPICAL | 540 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBCUTANEOUS | 1 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRAMUSCULAR | 9 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, EXTENDED RELEASE / ORAL | 8 mg | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, EXTENDED RELEASE / ORAL | 1.49 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, LIQUID FILLED / ORAL | 1.5 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRALESIONAL | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE, EXTENDED RELEASE / ORAL | 41 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT / TOPICAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAMUSCULAR | 90 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / ORAL | 11 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / VAGINAL | 10 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRALESIONAL | 0.9 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, EMULSION / INTRAVENOUS | 1.1 %w/v | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 89d9b005-7f25-436a-a976-38c75dab56b7 | 37154826-c34a-416d-a9a3-5004156dccd6 | 2014-01-16 | Warnings | 89d9b005-7f25-436a-a976-38c75dab56b7 37154826-c34a-416d-a9a3-5004156dccd6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.